BibTex Citation Data :
@article{JMKI44662, author = {Didiek Soegiantoro and Holy Soegiantoro and Gregory Soegiantoro}, title = {Rational Drug Use and Inventory Drug Management in the Peak of Covid-19 Pandemic in Indonesia}, journal = {Jurnal Manajemen Kesehatan Indonesia}, volume = {10}, number = {1}, year = {2022}, keywords = {rational drug use, purchasing lead time, cost of purchase, COVID-19, pharmacies}, abstract = { The rational use of drugs is characterized by the appropriate diagnosis, treatment, the appropriate drugs, dosage and duration, the appropriate information and counseling, and evaluation of treatment responses. Panic buying for medications used in the treatment of COVID-19, including prescribed drugs, resulted from public panic prompted by the high fatality rate of COVID-19. The demand for COVID-19 prescribed pharmaceuticals without a prescription refers to irrational drug use and uncontrollable growth in demand that has caused drug supply management issues. From June to August 2021, researchers conducted an observational study employing a cross-sectional analysis method from several pharmacies in each region. The findings revealed a more than 2-fold rise in demand for COVID-19 medications without a prescription, resulting in a more than 3-fold increase in purchasing lead times, as well as a more than 3-fold increase in drug purchase costs that could be regulated with government selling price standards. This study concludes that at the peak of the COVID-19 pandemic, there was an increase in irrational demand due to people's indiscipline to use rational drugs, resulting in drug scarcity and uncontrolled price increases. }, issn = {2548-7213}, pages = {20--27} doi = {10.14710/jmki.10.1.2022.20-27}, url = {https://ejournal.undip.ac.id/index.php/jmki/article/view/44662} }
Refworks Citation Data :
The rational use of drugs is characterized by the appropriate diagnosis, treatment, the appropriate drugs, dosage and duration, the appropriate information and counseling, and evaluation of treatment responses. Panic buying for medications used in the treatment of COVID-19, including prescribed drugs, resulted from public panic prompted by the high fatality rate of COVID-19. The demand for COVID-19 prescribed pharmaceuticals without a prescription refers to irrational drug use and uncontrollable growth in demand that has caused drug supply management issues. From June to August 2021, researchers conducted an observational study employing a cross-sectional analysis method from several pharmacies in each region. The findings revealed a more than 2-fold rise in demand for COVID-19 medications without a prescription, resulting in a more than 3-fold increase in purchasing lead times, as well as a more than 3-fold increase in drug purchase costs that could be regulated with government selling price standards. This study concludes that at the peak of the COVID-19 pandemic, there was an increase in irrational demand due to people's indiscipline to use rational drugs, resulting in drug scarcity and uncontrolled price increases.
Note: This article has supplementary file(s).
Article Metrics:
Last update:
Last update: 2024-11-23 21:45:47
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to JMKI journal and Master’s Study Program in Public Health, Faculty of Public Health, Diponegoro University as the publisher of the journal. Copyright encompasses rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms, and any other similar reproductions, as well as translations.
JMKI journal and Master of Public Health Study Program, Universitas Diponegoro and the Editors make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in JMKI journal are the sole and exclusive responsibility of their respective authors and advertisers.
The Copyright Transfer Form can be downloaded here: [Copyright Transfer Form JMKI]. The copyright form should be signed originally and send to the Editorial Office in the form of original mail, scanned document or fax :
Farid Agushybana, S.KM., Ph.D (Editor-in-Chief)Editorial Office of Jurnal Manajemen Kesehatan IndonesiaMaster of Public Health Study Program, Universitas DiponegoroJl. Prof. Soedarto, Kampus Undip Tembalang, Semarang, Central Java, Indonesia 50275Telp./Fax: +62-24-7460044Email: hybana@gmail.com / jmki@live.undip.ac.id
Jurnal Manajemen Kesehatan Indonesia (e-ISSN: 2548-7213, p-ISSN: 2303-3622) is published by Master of Publich Health, Faculty of Public Health, Universitas Diponegoro under a Creative Commons Attribution 4.0 International License.
View statistics